Skip to main content

An official website of the United States government

Sony Multi-Application (MA900) Cell Sorter

Waiver type - Procurement: Nonavailability

Agency: CENTERS FOR DISEASE CONTROL AND PREVENTION (7523) • Product Service Code (PSC) : 6640 | Last Modified: 09/13/2024

Procurement Summary

This is an acquisition of a MA900 Cell sorter. This cell sorter is needed to analyze and complete single-cell sorting of antigen-specific B cells needed to study the BCR repertoire in response to influenza vaccination/infection. This cell sorter will also serve a vital role in meeting the objectives of the influenza pandemic preparedness pipeline to produce monoclonal antibody therapeutics. The Sony MA900 has the modern technologies built into the system to include a patented microfluidic chip-based design, comprehensive fluidic controls, and advanced automation that dramatically simplifies operation to make sorting less subjective and improve reliability of results.

Waiver Rationale Summary

The Sony MA900 is a brand-name product manufactured in Japan. The manufacturer is the sole source provider of the instrument and does not allow vendors to resale of this product. This product is unique on the market and there are no comparable single items. It would take two (2) items to do what this product can do. It’s a comprehensive analyzer and cell sorter all in one small footprint which currently no other company, US or otherwise, can provide. Therefore, there is no domestic source that can meet the agency’s need.

Did / Will the solicitation include one of the standard BAA provisions announcing the agency’s intention to provide a price preference for domestic end products and construction material?

No

Was a sources sought or Request for Information issued?

No

OMB Determination

Consistent with Policy

Product

LABORATORY EQUIPMENT AND SUPPLIES

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Date Submitted

08/28/2024

Procurement Instrument Identifier (PIID)

75D31-24-Q-78309

Solicitation ID

75D31-24-Q-78309

Procurement Stage

Post-solicitation

Expected Maximum Duration of the Proposed Waiver

Instant Delivery Only

Waiver Coverage

Individual Waiver

Funding Agency

CENTERS FOR DISEASE CONTROL AND PREVENTION